Back to Search
Start Over
The role of mucoactive agents in the mechanically ventilated patient: a review of the literature.
- Source :
-
Expert review of respiratory medicine [Expert Rev Respir Med] 2017 Oct; Vol. 11 (10), pp. 807-814. Date of Electronic Publication: 2017 Jul 26. - Publication Year :
- 2017
-
Abstract
- Introduction: The management of airway secretions in the mechanically ventilated patient is a routine task throughout all intensive care units. The current treatment strategies are primarily based on anecdotal experiences rather than statistical evidence. Areas covered: This review article evaluates the data from published trials surrounding mucoactive agents and their use in the critically ill patient population. We completed an extensive search through PUBMED and CINAHL via EBSCO, along with the Cochran library to find all trials using mucoactive agents in the critically ill patient population. Expert commentary: Overall, the role of mucoactive agents in the intensive care unit is a field within pulmonary critical care that is in need of evidence-based recommendations. We feel that there is great opportunity for investigators to evaluate different mucoactive therapies in this patient population and to determine their effect on clinical outcomes.
- Subjects :
- Acetylcysteine therapeutic use
Ambroxol therapeutic use
Critical Care
Critical Illness
Deoxyribonuclease I therapeutic use
Guaifenesin therapeutic use
Humans
Intensive Care Units
Mannitol therapeutic use
Potassium Dichromate therapeutic use
Recombinant Proteins therapeutic use
Saline Solution, Hypertonic therapeutic use
Sodium Bicarbonate therapeutic use
Expectorants therapeutic use
Mucociliary Clearance
Respiration, Artificial
Subjects
Details
- Language :
- English
- ISSN :
- 1747-6356
- Volume :
- 11
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Expert review of respiratory medicine
- Publication Type :
- Academic Journal
- Accession number :
- 28737047
- Full Text :
- https://doi.org/10.1080/17476348.2017.1359090